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Abstract Mitochondrial ATP-sensitive K+ channel (mitoKATP)
opening was shown previously to slightly increase respiration
and decrease the membrane potential by stimulating K+ cycling
across the inner membrane. Here we show that mitoKATP open-
ing reduces reactive oxygen species generation in heart, liver
and brain mitochondria. Decreased H2O2 release is observed
when mitoKATP is active both with respiration stimulated by
oxidative phosphorylation and when ATP synthesis is inhibited.
In addition, decreased H2O2 release is observed when mitochon-
drial vpH is enhanced, an e¡ect expected to occur when
mitoKATP is open. We conclude that mitoKATP is an e¡ective
pathway to trigger mild uncoupling, preventing reactive oxygen
species release.
( 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Mitochondria continuously generate small amounts of
superoxide radical anions through monoelectronic reduction
of oxygen at intermediate steps of the electron transport
chain. These superoxide radicals then produce other reactive
oxygen species (ROS) such as hydrogen peroxide (H2O2),
through dismutation catalyzed by superoxide dismutases; hy-
droxyl radicals, from the reaction of H2O2 with Fe2þ ; or per-
oxynitrite, through combination of superoxide radicals with
nitric oxide, generated by the mitochondrial nitric oxide syn-
thase [1]. Mitochondrially generated ROS have been impli-
cated in cellular damage occurring in a variety of pathologies
including ischemia/reperfusion, Parkinson’s disease, Hunting-
ton’s disease and aging [1,2]. Thus, in order to establish better
therapeutic approaches for these conditions, it is important to
understand how mitochondrial ROS release is regulated.
> Respiratory rates and the inner membrane potential (v8)
are well-established regulators of ROS release. Low v8, ac-
companied by enhanced respiration, prevents mitochondrial
ROS release, while low respiratory rates strongly increase
ROS generation [3,4]. This seemingly contradictory ¢nding,
in which ROS release is lowest when oxygen consumption is
highest, is justi¢ed by the fact that low respiratory rates result
in longer life times for electron transport chain intermediates
capable of monoelectronically reducing oxygen, such as semi-
quinone radicals in the ubiquinone pool [3,4]. Indeed,
the activation of pathways which decrease v8 and increase
respiration, such as uncoupling proteins and plant alterna-
tive oxidases, strongly prevent mitochondrial ROS release
[5,6].
A recently described inner mitochondrial membrane chan-
nel, the ATP-sensitive Kþ channel (mitoKATP), is another
mechanism through which respiration and v8 are regulated
[7]. This channel promotes Kþ entrance into the mitochon-
drial matrix in a manner stimulated by v8. Enhanced Kþ
uptake through mitoKATP leads to increased mitochondrial
volume, faster respiration, lower v8 and, in the absence of
adequate levels of phosphate, increased vpH, with matrix al-
kalinization (for a review, see [8]). These mitoKATP e¡ects
could promote a decline in mitochondrial ROS production.
However, because Kþ transport rates through mammalian
mitoKATP are low, the respiratory and v8 e¡ects of this chan-
nel are limited. In fact, the v8 e¡ect of mitoKATP in heart is
so small it cannot be detected using conventional measure-
ments [7]. The result of such a small decrease in v8 and
respiratory increment on mitochondrial ROS release had not
been determined before this study.
Although mitoKATP activity could decrease mitochondrial
ROS release due to its respiratory e¡ect, studies using intact
cells have suggested the opposite: that mitoKATP opening
leads to increased ROS release [9^11]. This ¢nding is compat-
ible with the hypothesis that ROS participate in ischemic pre-
conditioning (the protective e¡ect of short ischemic periods on
a subsequent longer ischemic insult), in which mitoKATP acti-
vation is an essential step (for a review, see [12]). The mech-
anism through which ROS may increase with mitoKATP open-
ing has not been determined, but may be related to matrix
alkalinization [8].
In order to uncover the direct e¡ect of mitoKATP on mito-
chondrial ROS release and understand better the functional
role of mitoKATP, we measured H2O2 and total ROS gener-
ation in isolated mitochondria incubated under conditions in
which mitoKATP activity, respiration, v8 and vpH were ma-
nipulated.
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2. Materials and methods
2.1. Mitochondrial isolation
Brain mitochondria were isolated as described by Andreyev and
Fiskum [13], except protease was omitted. Heart and liver mitochon-
dria were isolated as described previously [7,14]. All experiments were
conducted within 3 h of mitochondrial isolation. Protein concentra-
tions were determined using the Biuret method.
2.2. H2O2 release measurements
Amplex Red (Molecular Probes) oxidation in the presence of extra-
mitochondrial horseradish peroxidase (HRP) bound to H2O2 gener-
ates resoru¢n, a highly £uorescent compound, with a 1:1 stoichiom-
etry [15]. Resoru¢n £uorescence was monitored using a temperature-
controlled Hitachi 4010 £uorescence spectrophotometer operating at
excitation and emission wavelengths of 563 nm and 587 nm, respec-
tively, with continuous stirring. Control experiments conducted in the
absence of Amplex Red or HRP indicated that changes in mitochon-
drial morphology or direct interactions between mitochondrial com-
ponents and Amplex Red do not alter resoru¢n £uorescence measure-
ments. In the absence of mitochondria, £uorescence increment rates
were negligible (not shown). In order to calibrate the results, a plot
relating £uorescence to the concentration of commercial resoru¢n was
constructed. Resoru¢n formation was then quanti¢ed in the experi-
mental traces, and assumed to be equal to released H2O2.
2.3. ROS measurements
Dichlorodihydro£uorescein diacetate (H2DCFDA) is a membrane-
permeable reagent oxidized by ROS such as H2O2 and nitric oxide,
generating £uorescent dichloro£uorescein diacetate (DCFDA) [16].
DCFDA £uorescence was monitored using a temperature-controlled
Hitachi 4010 £uorescence spectrophotometer operating at excitation
and emission wavelengths of 488 nm and 525 nm, respectively, with
continuous stirring.
2.4. Data analysis
Figs. 1A,C, 2 and 3 are representative data of at least three similar
repetitions using di¡erent mitochondrial preparations. Fig. 1B repre-
sents the averageQS.E.M. (standard error) of three di¡erent determi-
nations. Multiple pairwise Tukey tests performed by SigmaStat were
used to determine statistical signi¢cance.
3. Results
Brain mitochondria exhibit the highest levels of mitoKATP
protein and Kþ transport activity of any mammalian tissue
studied to date [17]. Predicting that any possible e¡ect of
mitoKATP on ROS release would be intensi¢ed in brain, we
initially used mitochondria isolated from this tissue to study
the e¡ects of mitoKATP on ROS release. In Fig. 1A, brain
mitochondrial H2O2 release was measured by following the
formation of the highly £uorescent compound resoru¢n due
to the oxidation of Amplex Red in the presence of HRP (see
Section 2 and [15]). Oligomycin was present in all traces to
prevent ATP synthesis or degradation through the ATP syn-
thase, and bovine serum albumin (BSA) was added to avoid
mitochondrial uncoupling due to contaminating fatty acids.
We found that under control conditions (line a), H2O2 release
rates were lower than those observed in the presence of ATP
(line b), which inhibits Kþ transport though mitoKATP
[1,8,17,18]. When the inhibitory e¡ect of ATP was overcome
by the concomitant presence of diazoxide (DZX), a mitoKATP
agonist [7,17], H2O2 release was lowered (line c) to levels
similar to those observed in control mitochondria. Con¢rming
that mitoKATP activity decreased H2O2 release, mitochondria
incubated in media in which Kþ was substituted by Naþ
(which is not transported by mitoKATP [19]) presented higher
H2O2 release rates (line d). The subsequent addition of the Hþ
ionophore FCCP (carbonyl cyanide 4-(tri£uoromethoxy)phe-
nylhydrazone) decreased H2O2 release rates to levels which
co
nt
ro
l
AT
P
AT
P+
D
ZX
no
 K
 
0.0
0.2
0.4
0.6
0.8
1.0
+
B
**
*
*
H
2
O
2
 R
e
le
a
s
e
 (
n
m
o
ls
 .
 m
in
-1
 .
 m
g
-1
)
0 5 10 15 20 25
400
600
800
1000
1200
1400
1600
A
FCCP
RBM
b
c
d
a
R
e
s
o
ru
fi
n
 F
lu
o
re
s
c
e
n
c
e
 (
A
.U
.)
Time (min)
0 5 10 15 20
10
20
30
40
C
RBM
d
c
b
a
D
C
F
D
A
 F
lu
o
re
s
c
e
n
c
e
 (
A
.U
.)
Time (min)
Fig. 1. Kþ transport through mitoKATP decreases ROS release in brain mitochondria. Rat brain mitochondria (RBM, 0.2 mg/ml) were added
to reaction media at 37‡C containing 150 mM KCl, 10 mM HEPES, 2 mM Mg2þ, 1 mM EGTA, 1 mM Pi, 2 mM malate, 2 mM glutamate,
1 mg/ml BSA, 2 Wg/ml oligomycin, pH 7.2 (KOH). Amplex Red (50 WM) and 1 U/ml HRP (panels A and B) or 10 WM H2DCFDA (panel C)
were present to measure ROS production under control conditions (no further additions, lines a) or in the presence of 1 mM ATP (lines b),
1 mM ATP and 10 WM DZX (lines c), or no further additions, in a media in which all Kþ salts were substituted for Naþ (lines d). FCCP
(2 WM) was added where indicated. Panel B represents averageQS.E.M. H2O2 release rates, observed between 10 and 20 min after mitochon-
drial addition using three di¡erent mitochondrial preparations. *P6 0.05 compared to control, **P6 0.05 compared to the experiment con-
ducted in the presence of ATP.
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were not signi¢cantly di¡erent under any of the conditions
tested.
Fig. 1B shows average H2O2 release rates under the con-
ditions described above, and indicates that a lack of mitoKATP
activity (hatched columns) results in a statistically signi¢cant
increment (approximately 35%) in mitochondrial H2O2 release
rates, compared to mitochondria in which mitoKATP is active
(empty columns).
In order to ensure the accuracy of our results, we measured
ROS generation using a second £uorescent product, DCFDA,
which is formed by the oxidation of H2DCFDA promoted by
H2O2 and nitric oxide (and possibly other ROS). Despite the
lower sensitivity of DCFDA, we observed (Fig. 1C) that mi-
tochondria with mitoKATP open in the absence of ATP or the
presence of ATP plus DZX (lines a and c, respectively) pre-
sented lower rates of ROS production than those in which
mitoKATP activity was inhibited by ATP or the lack of Kþ
(lines b and d, respectively).
In order to verify if the decrease in mitochondrial ROS
release promoted by mitoKATP activity is related to the higher
activity of this channel in brain [17], we performed similar
measurements in mitochondria isolated from heart and liver
(Fig. 2). Despite the lower mitoKATP-dependent Kþ transport
rates in these tissues (in heart, rates are so low v8 changes are
not measurable [7,17]), we found that mitoKATP opening
(open columns) lead to a decrease in H2O2 release compared
to conditions in which mitoKATP activity is inhibited (hatched
columns). On average, heart mitochondrial H2O2 release was
increased by 28%, while liver mitochondria displayed 18%
more H2O2 release when mitoKATP was closed. Thus, even
low Kþ transport rates through liver and heart mitoKATP
are su⁄cient to signi¢cantly reduce ROS generation.
The experiments in Figs. 1 and 2 were conducted in the
presence of oligomycin, in order to prevent changes in respi-
ratory rates promoted by the addition of ATP, which often
contains low quantities of contaminating ADP. However, mi-
tochondria within intact cells usually phosphorylate ADP, a
process that increases respiratory rates, reduces v8 and de-
creases ROS release. In Fig. 3, we measured the e¡ect of
mitoKATP activation in brain mitochondria in which ATP
synthesis was induced by adding excess ADP. In the presence
of ADP, which inhibits mitoKATP [18], mitochondria oxidized
Amplex Red at slower rates than in the absence of oxidative
phosphorylation, as expected due to elevated respiratory rates
and lower v8 [3,4]. Interestingly, even under these conditions,
mitoKATP activation by DZX leads to a measurable decrease
in H2O2 formation. This e¡ect of mitoKATP activation was
not observed in the absence of Kþ ions, con¢rming that in-
creases in Kþ cycling through mitoKATP activity decrease
H2O2 release.
In intact cells, a relative lack of the membrane-permeable
anion inorganic phosphate (Pi) may occur, and mitoKATP
activity can generate a vpH gradient across the inner mito-
chondrial membrane [8], with intense matrix alkalinization.
This alkalinization has been suggested to be the cause of pos-
sible ROS increases observed in intact cells when mitoKATP
was activated [8,11]. We investigated the e¡ect of matrix al-
kalinization on mitochondrial H2O2 release. Mitochondria in-
cubated in the presence of excess Pi, a condition in which
matrix alkalinity is minimal, present H2O2 release rates higher
than those incubated in the absence of added Pi (Fig. 3), a
condition in which vpH and matrix alkalinity are increased.
Under these conditions, mitoKATP inhibition by ATP does
not signi¢cantly a¡ect H2O2 release.
4. Discussion
Using isolated mitochondria from brain (Figs. 1 and 3),
heart and liver (Fig. 2), we found that mitochondrial ROS
generation is signi¢cantly decreased when mitoKATP is active.
Increased mitochondrial vpH, an e¡ect expected to occur
within intact cells when mitoKATP is highly active [8], also
decreased ROS release (Fig. 3). The decreased ROS produc-
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Fig. 2. Kþ transport through mitoKATP decreases H2O2 release in
heart and liver mitochondria. Rat heart or liver mitochondria (0.2
mg/ml) were added to the reaction media described in Fig. 1, in the
presence of 50 WM Amplex Red, 1 U/ml HRP and (control) no fur-
ther additions, (ATP) 1 mM ATP, (ATP+DZX) 1 mM ATP and 10
WM DZX, or (no Kþ) no further additions, in a media in which all
Kþ was substituted for Naþ. H2O2 release rates were determined as
described in Section 2, between 10 and 20 min after mitochondrial
addition.
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Fig. 3. E¡ect of oxidative phosphorylation and lack of Pi on
mitoKATP-regulated H2O2 release. Rat brain mitochondria (0.2 mg/
ml) were added to the reaction media described in Fig. 1, in the
presence of 50 WM Amplex Red, 1 U/ml HRP and (control) no fur-
ther additions; (ATP) 1 mM ATP; (ADP) 2 mM ADP in the ab-
sence of oligomycin; (ADP+DZX) 2 mM ADP and 10 WM DZX,
in the absence of oligomycin; (ADP+DZX, no Kþ) 2 mM ADP
and 10 WM DZX in the absence of oligomycin, in a media in which
all Kþ was substituted for Naþ ; (no Pi) no further additions, in me-
dia devoid of Pi ; (no Pi+ATP) 1 mM ATP, in the absence of Pi.
H2O2 release rates were determined as described in Section 2, be-
tween 10 and 20 min after mitochondrial addition.
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tion promoted by mitoKATP occurs both in the absence (state
4, Figs. 1 and 2) and presence (state 3, Fig. 3) of oxidative
phosphorylation, and is in line with the ¢nding that mild
uncoupling between respiration and oxidative phosphory-
lation strongly prevents mitochondrial ROS formation [3^6].
However, these results di¡er from ¢ndings using intact cells,
in which the addition of DZX promoted an apparent increase
in mitochondrial ROS [9^11].
The reason for these con£icting results is not immediately
clear, but may re£ect di¡erences in the experimental proto-
cols. While previous papers measured ROS within intact vas-
cular cells, this study used isolated mitochondria, an approach
which we ¢nd interesting, since it allows us to activate
mitoKATP both by omitting ATP from the reaction medium
and by adding DZX to counteract the ATP e¡ect. In isolated
mitochondria, it is also possible to test if the e¡ects of these
additions can be directly attributed to mitoKATP by repeating
the tests in media devoid of Kþ salts. In intact cells, mitoKATP
can only be regulated using pharmacological tools, which may
present artifacts [7]. In addition, mitoKATP opening in intact
cells may not directly enhance mitochondrial ROS generation,
but may activate other intracellular pathways responsible for
ROS production.
Another possible reason for the discrepancy between our
results and previous measurements of mitoKATP-stimulated
ROS release in intact cells is the use of di¡erent £uorescent
probes. We used primarily Amplex Red in our measurements,
which is oxidized speci¢cally by HRP-bound H2O2 to form
the £uorescent product resoru¢n. We ¢nd the speci¢city, high
sensitivity and low noise of this probe very useful in H2O2
measurements. We also ¢nd that Amplex Red measurements
respond as expected to conditions known to increase and
decrease mitochondrial ROS, such as respiratory inhibition
with antimycin A (results not shown) and respiratory stimu-
lation with FCCP (Fig. 1A), respectively. Another ¢nding
supporting the idea that our measurements accurately mea-
sure mitochondrial H2O2 are the similar results obtained us-
ing the less speci¢c and sensitive indicator H2DCFDA (Fig.
1C).
H2DCFDA was previously used by Forbes and co-authors
[9] to measure ROS in intact cardiac myocytes treated with
DZX and pinacidil to induce mitoKATP opening. In contrast
to our results, these authors observed an increase in £uores-
cence increment of this probe when mitoKATP was open.
Again, this result may re£ect indirect e¡ects of mitoKATP
opening on ROS generation in intact cells, not observed in
isolated mitochondria. Another possibility for these di¡ering
results may be that the authors loaded the cells with
H2DCFDA before their measurements, allowing the genera-
tion of intracellular dichlorodihydro£uorescein, a membrane-
impermeable metabolite of H2DCFDA [9]. Due to its negative
charge, this compound may redistribute within the cell de-
pending on mitochondrial vpH and v8, parameters that are
altered by mitoKATP opening [7,17].
Other previous investigations of mitoKATP e¡ects on ROS
generation used reduced Mitotracker probes (Mitotracker
Red and Orange, [10,11]) in vascular cell lines. In one of these
studies, the authors found that neither the uncoupler dinitro-
phenol nor the respiratory inhibitor myxothiazol cause a
change in the probe’s £uorescence under control conditions
[11]. This unusual result may indicate that these probes are
not, in fact, accurately measuring ROS. Moreover, these au-
thors found that the mitoKATP e¡ect in intact cells was not
observed using more traditional ROS indicators such as
H2DCFDA (ref. [11] as opposed to the results of ref. [9])
and dihydroethidium [10]. According to the maker (Molecular
Probes), reduced Mitotracker Red and Orange do not £uo-
resce until they enter a respiring cell, where they are oxidized
by ROS and sequestered in mitochondria as £uorescent prod-
ucts. It is possible that mitochondrial sequestration of these
dyes is a¡ected by other factors controlled by mitoKATP, in-
cluding v8, vpH and, most importantly, volume [7]. We have
previously shown that changes in mitochondrial volume may
strongly a¡ect uncalibrated £uorescent measurements using
many di¡erent dyes [20], and mitoKATP opening is known
to signi¢cantly increase mitochondrial volume [7,10,17].
The hypothesis that mitoKATP opening could increase mi-
tochondrial ROS release was developed based on experiments
showing that ischemic preconditioning in heart involves both
the activation of mitoKATP and increased cellular ROS
[12,21]. Since ROS generation appeared to occur downstream
of mitoKATP activation [22,23], it seemed logical to propose
that it was mediated by this channel. However, there is solid
evidence today that ROS are increased in preconditioned
hearts upstream of mitoKATP activation [24], through yet un-
determined mechanisms. In view of this data, it is possible
that mitoKATP opening is not directly involved in the increase
in ROS observed after preconditioning. However, the results
in this manuscript may explain the preventive e¡ect of ische-
mic preconditioning on ROS release observed after ischemia/
reperfusion, an e¡ect related to mitoKATP activation [25].
Independently of the controversy regarding ischemic pre-
conditioning and ROS, the ¢nding that mitoKATP decreases
mitochondrial ROS release suggests many interesting possibil-
ities. We ¢nd the e¡ect of this channel an ideal method to
regulate mitochondrial ROS generation, since Kþ transport
through mitoKATP is limited by the low quantity and trans-
port rates of this channel, and does not seriously a¡ect other
mitochondrial functions such as oxidative phosphorylation,
Ca2þ uptake and v8 [7]. Thus, mitoKATP opening may
have a physiological role as an endogenous prevention mech-
anism against excessive mitochondrial ROS formation, with-
out hampering mitochondrial function. The ¢nding that
mitoKATP activity is stimulated by oxidation promoted by
ROS [26,27] further supports this hypothesis. Also, unlike
uncoupling proteins (which promote mild mitochondrial un-
coupling and prevent ROS release [5]), mitoKATP has well
known pharmacological regulators. These mitoKATP regula-
tors may be e¡ective tools in the prevention of diseases related
to mitochondrial ROS accumulation.
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